Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an announcement.
Integral Diagnostics director Ingrid Anne Player has increased her indirect shareholding in the company, reflecting a higher personal financial exposure to the medical imaging provider. Her interests are held through Pisi Pty Ltd as trustee of The Huybers Family Account, where she is a director, shareholder of the trustee, and a beneficiary of the trust.
On 27 February 2026, Player acquired 25,000 fully paid ordinary shares via an on-market trade at $2.4161 per share, lifting her indirect holding from 35,000 to 60,000 shares. The transaction, which did not occur during a closed trading period, may be seen as a signal of confidence in Integral Diagnostics’ prospects by a member of its board.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Limited operates in the medical imaging and diagnostics sector, providing radiology and related diagnostic services. The company focuses on delivering imaging solutions such as X-ray, CT, MRI, and other scans to healthcare providers and patients across its network of clinics and facilities.
Average Trading Volume: 706,778
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$909.4M
Learn more about IDX stock on TipRanks’ Stock Analysis page.